Rubicon Research Ltd (RUBICON)
·Next Day Close·+1.58%·₹1,614.1
Key EventTrading window closes before financial results release
Rubicon Research Ltd (RUBICON)
·Next Day Close·+0.66%·₹1,817.65
Key EventPromoter General Atlantic Singapore RR Pte Ltd sold 1.4 million shares
ImpactThe promoter has partially divested its stake, lowering its controlling influence in the company.Sign up to read impact
Rubicon Research Ltd (RUBICON)
·Next Day Close·-1.95%·₹1,805.8
Key EventPromoter sells 1.46 million and 13.85 million shares
ImpactThe promoter is reducing its holding, signaling potential lack of confidence or portfolio rebalancing.Sign up to read impact
Rubicon Research Limited (RUBICON)
·Next Day Close·+1.47%·₹1,841.65
Key EventRubicon Research held its 27th AGM on August 26, 2026, approving financials, dividend, and merger.
ImpactShareholders approved key governance and capital decisions, including dividend and merger, signaling strategic focus on growth and shareholder returns.Sign up to read impact
Rubicon Research Limited (RUBICON)
·Next Day Close·-1.98%·₹1,762.2
Key EventRubicon Research reported Q1 FY27 revenue of ₹534 crores, up 51% YoY, with PAT at ₹85 crores (+95%).
ImpactRubicon is scaling profitably with strong margin expansion, rising R&D productivity, and strategic US manufacturing investments to drive future growth and resilience.Sign up to read impact
Rubicon Research Limited (RUBICON)
·Next Day Close·+11.15%·₹1,798.3
Key EventAudio recording of earnings conference call released
ImpactShareholders can now listen to the full earnings discussion to assess performance and outlook.Sign up to read impact
Rubicon Research Limited (RUBICON)
·Next Day Close·+11.15%·₹1,798.3
Key EventRubicon Research Limited showcased Q1 FY27 results and strategic acquisition plans during its August 14, 2026 investor presentation.
ImpactShareholders gain exposure to high-growth specialty pharmaceuticals with expanding US manufacturing capabilities and proven regulatory compliance.Sign up to read impact
Rubicon Research Limited (RUBICON)
·Next Day Close·+11.15%·₹1,798.3
Key EventBoard approved merger scheme and Arinna Lifesciences acquisition
ImpactThe acquisitions signal expansion into new markets but may pressure short-term profitability due to integration costs.Sign up to read impact
Rubicon Research Limited (RUBICON)
·Next Day Close·-0.25%·₹1,617.95
Key EventRubicon Research Limited reported FY26 revenue growth of 37% to INR 17,540 million and 52% EBITDA growth to INR 4,002 million, with PAT up 84% to INR 2,467 million.
ImpactRubicon's strong financial performance, specialty product growth, and strategic acquisitions position it for sustained growth in regulated markets, but investors should monitor execution risks in Pithampur ramp-up and integration of new acquisitions.Sign up to read impact
Rubicon Research Limited (RUBICON)
·Next Day Close·+2.6%·₹1,595.75
Key EventRubicon Research schedules earnings conference call for August 14, 2026
ImpactInvestors can gain insights into quarterly results and management's outlook during the call.Sign up to read impact